^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    XKDCT080

    i
    Other names: XKDCT 080, CT-080, XKDCT-080, XKDCT080, CT080, CT 080
    Associations

    News

    Trials
    Company:
    First Condor Biotech
    Drug class:
    GUCY2C-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation (clinicaltrials.gov)
    P=N/A, N=9, Recruiting, The Affiliated Hospital of Qingdao University
    New trial
    |
    XKDCT080